Why Applied DNA Sciences Shares Are Trading Lower By Around 68%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
$ABL
$AGIO
$AKAN
$APDN
Investment Managers
Finance
Biotechnology: Pharmaceutical Preparations
Health Care
Shares of Applied DNA Sciences, Inc. (NASDAQ:APDN) fell sharply during Tuesday's session after the company announced the pricing of a $12 million public offering.
Applied DNA Sciences shares tumbled 67.5% to $0.6468 on Tuesday.
Here are some other stocks moving in today’s mid-day session.
Gainers
- Sharps Technology, Inc. (NASDAQ:STSS) shares climbed 207% to $0.6579 after jumping around 13% on Friday.
- Insmed Incorporated (NASDAQ:INSM) jumped 110% to $46.20 after the company announced topline results from ASPEN Phase 3 study met its primary endpoint.
- Pineapple Energy Inc. (NASDAQ:PEGY) shares gained 91.5% to $0.3411 after the company on Friday announced its SUNation subsidiary signed a 1.95-megawatt project.
- Calliditas Therapeutics AB (NASDAQ:CALT) shares gained 74.6% to $38.10 after the company’s board recommended the acceptance of Asahi Kasei’s tender offer.
- Visionary Holdings Inc. (NASDAQ:GV) rose 68% to $0.3350. Visionary Holdings said that the company has successfully transformed into a high-innovation and high growth company.
- Oblong, Inc. (NASDAQ:OBLG) surged 57% to $0.2841.
- Latam Logistic Properties, S.A. (NYSE:LPA) rose 45.2% to $20.47.
- Predictive Oncology Inc. (NASDAQ:POAI) jumped 37% to $2.1801 after the company announced results from its ovarian caner study with UPMC Magee-Womens Hospital.
- Trinity Place Holdings Inc. (NASDAQ:TPHS) rose 35% to $0.1837.
- Exicure, Inc. (NASDAQ:XCUR) gained 31% to $0.4359.
- Virgin Galactic Holdings, Inc. (NYSE:SPCE) rose 30% to $1.1000.
- Kuke Music Holding Limited (NYSE:KUKE) gained 24.2% to $3.2781. Kuke Music signed a non-binding term sheet with Naxos One Holding.
- Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) rose 22% to $38.29 after the company announced it agreed to sell its rights to its 15% royalty on potential U.S. net sales of Servier’s vorasidenib to Royalty Pharma.
- Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) gained 21% to $36.63 after the company announced it will present Phase 1 results in healthy volunteers and new Phase 1b interim data in CF patients for ARCT-032.
- Crown ElectroKinetics Corp. (NASDAQ:CRKN) shares rose 19.3% to $0.1205 after dipping over 10% on Friday.
- Ocean Power Technologies, Inc. (NASDAQ:OPTT) shares gained 16.7% to $0.2240 after gaining around 5% on Friday.
- GameStop Corp. (NYSE:GME) gained 14.4% to $0.3411 after the company announced it has completed its at-the-market equity offering program, which was previously announced.
- Corcept Therapeutics Incorporated (NASDAQ:CORT) climbed 13.7% to $31.20 after the company announced that its Phase 3 GRACE trial met its primary endpoint.
- Forward Air Corporation (NASDAQ:FWRD) rose 13% to $13.93.
- NuScale Power Corporation (NYSE:SMR) gained 11.7% to $8.68 after jumping over 16% on Friday.
- Nukkleus Inc. (NASDAQ:NUKK) rose 10.9% to $1.0201.
- Abacus Life, Inc. (NASDAQ:ABL) gained 10.1% to $11.78.
- Oklo Inc. (NYSE:OKLO) rose 10.1% to $11.18.
- HubSpot, Inc. (NYSE:HUBS) gained 6.9% to $631.00.
Losers
- Marpai, Inc. (NASDAQ:MRAI) shares fell 54.7% to $0.6468 after the company announced its intention to withdraw from the Nasdaq hearings process.
- Innovative Eyewear, Inc. (NASDAQ:LUCY) shares fell 47.4% to $0.5170 after surging 428% on Friday.
- Sintx Technologies, Inc. (NASDAQ:SINT) fell 41% to $8.00.
- Netcapital Inc. (NASDAQ:NCPL) dipped 27.7% to $0.1390 after the company announced that it entered into definitive agreement for the immediate exercise of $2.2 million of certain outstanding Series A-2 warrants.
- OneMedNet Corporation (NASDAQ:ONMD) shares fell 24.4% to $1.77 after jumping 56% on Friday. OneMedNet, last week, highlighted a ‘five-fold expansion’ of its iRWD network and platform.
- Summit Therapeutics Inc. (NASDAQ:SMMT) fell 22.8% to $2.61.
- Akanda Corp. (NASDAQ:AKAN) shares fell 18.5% to $3.35 following a 72% surge on Friday. The international medical cannabis company implemented a 1-for-40 reverse stock split on its ordinary shares effective May 23, 2024, according to a recent exchange filing.
- SolarMax Technology, Inc. (NASDAQ:SMXT) fell 17.8% to $8.25.
- G1 Therapeutics, Inc. (NASDAQ:GTHX) declined 17.6% to $3.37.
- Edible Garden AG Incorporated (NASDAQ:EDBL) fell 15.6% to $1.8399.
- HilleVax, Inc. (NASDAQ:HLVX) fell 13.6% to $11.14.
- Celsius Holdings, Inc. (NASDAQ:CELH) dipped 13.3% to $82.08.
- Ryde Group Ltd. (NYSE:RYDE) declined 12.6% to $9.38.
- Novavax, Inc. (NASDAQ:NVAX) fell 12.4% to $13.56.
- NWTN Inc. (NASDAQ:NWTN) declined 12.3% to $3.52. NWTN received expected notification from the Nasdaq related to delayed annual report on Form 20-F.
- DraftKings Inc. (NASDAQ:DKNG) dipped 11% to $36.29 after the Illinois Senate approved a 2025 budget that includes a sports betting tax hike.
- Merus N.V. (NASDAQ:MRUS) fell 9.5% to $54.28 as the company revealed interim results for bispecific antibody petosemtamab with pembrolizumab at 2024 American Society of Clinical Oncology Annual Meeting.
- Moderna, Inc. (NASDAQ:MRNA) dipped 9.2% to $151.28.
- Sarepta Therapeutics, Inc. (NASDAQ:SRPT) declined 9.1% to $112.24 after RBC Capital downgraded the stock from Outperform to Sector Perform.
- Minim, Inc. (NASDAQ:MINM) shares fell 8.6% to $3.91 after gaining 33% on Friday.
- Applied UV, Inc. (NASDAQ:AUVI) shares fell 8.5% to $0.2879. Applied UV shares fell around 34% on Friday after the company reportedly filed for Chapter 11 bankruptcy.
- Loar Holdings Inc. (NYSE:LOAR) declined 7% to $51.36.
- Sea Limited (NYSE:SE) declined 6% to $67.75 after the company’s Shopee was reportedly accused of suspected anti-competition breaches in Indonesia.
- Hello Group Inc. (NASDAQ:MOMO) fell 5.8% to $5.20 following first-quarter results.
Now Read This: $1.5M Bet On This Healthcare Stock? Check Out These 4 Stocks Insiders Are Buying